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This study evaluated the frequency and severity of pru-
ritus and dry skin in children with chronic kidney di-
sease (CKD). A total of 103 children were included: 72 
with CKD stage 3–5 (34 on dialysis and 38 treated con-
servatively without dialysis) and 31 as a reference group. 
Pruritus was assessed using the 4-item Itch Questionnai-
re and a visual analogue scale. Skin dryness was evalua-
ted clinically, by non-invasive assessment of epidermal 
hydration and measurement of transepidermal water 
loss. Pruritus occurred in 20.8% of children with CKD, 
18.4% on conservative treatment (receiving supportive 
care without dialysis) and 23.5% on dialysis. Xerosis was 
more common in children with pruritus (66.7%) than in 
those without pruritus (50.9%). Patients with pruritus 
had a significantly lower estimated glomerular filtration 
rate and a higher ratio of calcium × phosphate product 
(Ca × P). In conclusion, CKD-associated pruritus occurs 
not only in adults, but also in children, and it may al-
ready be present in the early stages of CKD. Key words: 
pruritus; dry skin; chronic kidney disease; children.
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Cutaneous lesions in patients with chronic kidney disease 
(CKD) are polymorphic and diverse. The most common 
skin symptom in adults with CKD is pruritus, termed 
“uraemic pruritus” or, more accurately, “chronic kidney 
disease-associated pruritus” (CKD-P). CKD-P affects 
25% of patients on haemodialysis, according to a repre-
sentative cross-sectional study, but may occur in up to 
46% of patients depending on the country and haemodia-
lysis unit in which they are treated (1, 2). Pruritus is less 
common in patients with less advanced stages of CKD 
(2). A recent study by Solak et al. (3) found that pruritus 
occurred in 18% of predialysis patients with CKD. 
Our knowledge of the pathophysiological mechanism 
of CKD-P is incomplete. A number of hypotheses re-
garding its aetiopathogenesis have been put forward in 
the last 20–30 years, including: changes associated with 
dry skin, uraemic toxaemia, imbalance in divalent ions, 
proliferation of mast cells with a simultaneous increase 
in histamine levels, decreased levels of vitamin D, lipid 
dysregulation in the epidermis, hyperparathyroidism, 
abnormal tryptase and chymase activity, neurogenic 
disturbances, opioid receptor imbalance, and types of 
dialysis membranes (4–7). 
Published data on pruritus in children with CKD 
are limited. There are few published papers on pruritus 
in paediatric patients, and these present the results of 
studies on a small number of patients who need chronic 
renal replacement therapy (8, 9). No studies of pruritus 
in children with CKD in earlier stages of the disease have 
been published recently. The burden of pruritus is often 
underestimated by nephrologists, particularly in this 
group of patients with CKD. However, itch is one of 
the most frustrating symptoms, significantly influencing 
daily activities, disrupting sleep and impairing health-
related quality of life (10). 
The aims of the current study were to evaluate pruritus 
in children with different stages of CKD, to determine the 
prevalence of CKD-P, its severity and characteristics in 
these patients, and to examine its link with dry skin and 
selected factors typical for CKD.
MATERIALS AND METHODS
Patients
A total of 103 children from 3 Polish paediatric nephrology 
centres located in Wroclaw, Krakow and Zabrze were included 
in the study. Among them, there were 72 patients with CKD 
stages 3–5 and 31 patients with primary monosymptomatic 
nocturnal enuresis (17 girls and 14 boys, mean age 10.7 ± 3.9 
(range 4–17) years) who served as a reference group. A total 
of 38 patients with CKD were given conservative treatment 
(supportive care without dialysis) and 34 were given renal 
replacement therapy (20 haemodialysis subjects and 14 peri-
toneal dialysis subjects) (Table I). All dialysed patients were 
combined into a single group, as the numbers of patients on 
haemodialysis and peritoneal dialysis were low.
None of the children with CKD had had any dermatological 
treat ment, infection, or other condition in at least the 4 weeks 
prior to enrolment in the study that might have significantly in-
fluenced skin function. Haemodialysis was performed 3 times a 
week for 4 h using polysulphone dialysers. Patients were dia-
lysed using acetate and bicarbonate concentrate with standard 
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potassium and calcium concentrations. All assessments were 
conducted during hospitalization on days when haemodialysis 
was not performed, when patients stay in the hospital for check-
ups. In the group of patients treated with automated peritoneal 
dialysis (APD) Baxter Peritoneal Dialysis Solutions (1.36% 
glucose) (Warsaw, Poland) were administered. Physioneal® 
and/or Extraneal® were used if required. APD lasted for 12 h 
on average. Examination was carried out during the patient’s 
stay in the nephrology centre.
None of the children in the reference group had any chronic 
disease except primary monosymptomatic nocturnal enuresis. 
These children were not on any pharmacotherapy. Also, they 
had no acute infections or other acute conditions within the 
4-week period prior to the study.
Before entering the study children and their carers gave their 
informed consent for participation in the study; they were 
also informed of their right to leave the study at any time. The 
study protocol was approved by Wroclaw Medical University 
bioethics committee (KB-751/2012). 
Study design 
Each participant was assessed for pruritus and dryness of the 
skin. Patients with CKD also underwent blood tests. Data on 
the occurrence of pruritus, both at the time of the examination 
and previously, and its duration and location were collected. 
Pruritus intensity was assessed using a visual analogue scale 
(VAS) and a 4-item Itch Questionnaire to evaluate the extent, 
intensity, frequency of itch and sleep disturbances caused by 
pruritus (11, 12). The questionnaire scoring ranged from 3 
(mildest itch) to 19 points (most severe itch) (12, 13). Patients 
used the VAS to report the maximal intensity of their pruritus 
within the previous 24 h. In children under the age of 7 years, 
a modified VAS scale, based on the Wong-Baker Faces Pain 
Rating Scale, was used (14).
General dryness of the skin was initially assessed as absent, 
mild, moderate, or severe by the study subjects themselves. If 
necessary, self-reported assessment of the severity of skin dry-
ness was performed with the help of parents (especially in very 
young children). Skin dryness was then assessed by a derma-
tologist at 4 locations: forearm, lower leg, abdomen and chest, 
using the above-mentioned 4-point scale. Subsequently, non-
invasive corneometric assessment of epidermal hydration, using 
a Corneometer CM825 (Courage+Khazaka Electronic GmbH, 
Köln Germany), and measurement of trans epidermal water 
loss (TEWL), using a Tewameter TM300 (Courage+Khazaka 
Electronic GmbH), were carried out. Corneometer results were 
given in arbitrary units (AU), with a reduction in these values 
indicating a decrease in water content in the outer layers of the 
epidermis. TEWL values, reflecting skin barrier integrity, were 
given in g/h/m2. All measurements were performed on 4 areas 
of the skin: forearm, lower leg, abdomen and chest, at stable 
room temperature (20–22°C) and air humidity (40–50%) after 
a 10-min rest in the sitting position.
Statistical analysis
Microsoft Office Excel 2010 software (Microsoft Corporation, 
Warsaw, Poland) and Statistica 10.0 (Statsoft, Krakow, Poland) 
were used for statistical analysis of all data. Frequencies (per-
centage values) were calculated for qualitative parameters, 
while means and standard deviations were calculated for 
normally distributed quantitative variables, and medians and 
quartiles for skewed variables. The χ2 test, Student’s t-test, 
Mann–Whitney U test, analysis of variance (ANOVA) and 
Spearman’s rank correlation test were used, where appropriate. 
Statistical significance level was set at 0.05.
RESULTS
Pruritus occurred in 20.8% of the children with CKD. 
CKD-P was observed in 18.4% of the group of patients 
treated conservatively (without dialysis) and in 23.5% 
of those on dialysis (both on haemodialysis or APD). In 
all cases the pruritus was chronic (lasting longer than 
6 weeks). Pruritus was not diagnosed in any child in 
the control group. The mean severity of pruritus in all 
patients with CKD-P was 6.9 points according to the 
4-item Itch Questionnaire, and 3.5 points on the VAS. 
The characteristics of pruritus in CKD are shown in 
Table II. There was no difference between children 
treated conservatively and those dialysed with regard 
to the severity of itching according to the 4-item Itch 
Questionnaire and VAS, or the duration, or location 
of itching (Table II). Importantly, children on dialysis 
more often had generalized pruritus (87.5% of the 
children with pruritus) compared with 28.6% of pru-
ritic subjects treated conservatively without dialysis. 
Among the children with CKD, the subgroups with 
Table I. Characteristics of examined chronic kidney disease 
(CKD) groups
Characteristics
CKD on 
conservative 
treatment 
n = 38
CKD on 
dialysis 
n = 34 p-value
Age, years, mean ± SD 11.0 ± 4.5 11.1 ± 4.2 0.95
Sex, n (%) <  0.001
Male   8 (21.1) 22 (64.7)
Female 30 (78.9) 12 (35.3)
Cause of CKD, n (%)
  Urinary tract anomaly 
  Polycystic kidney disease
  Chronic glomerulonephritis
  Chronic interstitial nephropathy
  Other
23 (60.5)
  7 (18.4)
  3 (7.9)
  4 (10.5)
  1 (2.6)
13 (38.2)
  6 (17.6)
  7 (20.6)
  4 (11.8)
  4 (11.8)
0.2
CKD duration, years, mean ± SD   7.3 ± 4.9   7.4 ± 4.8 0.98
CKD stage, n (%) 
  3
  4
  5
20 (52.6)
18 (47.4)
  0
  0
  0
34 (100)
Table II. Characteristics of chronic kidney disease (CKD) children 
with pruritus 
CKD children 
on conservative 
treatment 
n = 7
CKD children 
on dialysis 
n = 8 p-value
Duration of pruritus, yearsa 2.5 (1.2–3) 3 (2–4) 0.38
Intensity of pruritus (4-item Itch 
Questionnaire)a
5 (5–8) 7.5 (6.5–8.5) 0.12
Intensity of pruritus (VAS)a 4.3 (0.8–4.4) 3.8 (2.9–4.2) 0.91
Generalized pruritus, n (%) 2 (28.6) 7 (87.5) 0.02
Multiple choice possible.
aMedian and first and third quartile or number of patients and percentages.
VAS: visual analogue scale.
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pruritus (n = 15) and without pruritus (n = 57) did not 
differ significantly with regard to age (p = 0.3), sex 
(p = 0.77), causes of CKD (p = 0.43), stage of CKD 
(p = 0.65) or duration of CKD (p = 0.43). The group 
of patients with pruritus had a significantly lower 
estimated glomerular filtration rate (eGFR) compared 
with the group without pruritus; median 13.18 (range 
7.7–23.4) ml/min vs. 21.04 (range 11.8–33.04) ml/min, 
p = 0.03) and a statistically significant higher ratio of 
the calcium × phosphate product (Ca × P) (median 49.6 
(range 44–66) mg2/dl2 vs. 40.6 (range 31.2–49.7) mg2/
dl2, p = 0.015) were noted.
Xerosis was more common in children with pruritus 
(66.7%) compared with those without pruritus (50.9%) 
(p < 0.01). Dry skin was identified more frequently in 
patients on dialysis (67.6%) than in those on conser-
vative treatment without dialysis (42.1%) (p < 0.01). 
Patients with pruritus more frequently had signs of 
increased skin dryness on the forearms and lower legs, 
but there were no significant differences between the 
groups regarding skin dryness in other locations. Xero-
sis was also more severe in children with pruritus than 
in those without pruritus (Table III). In addition, there 
were no differences between the groups with and with-
out pruritus with regard to the duration of dryness of 
the skin, the degree of skin hydration and TEWL values 
(Table III). No significant correlations were observed 
between the severity of pruritus, and the subjects’ age, 
CKD duration, duration of skin dryness or results of 
laboratory examinations (serum creatinine, parathyroid 
hormone (PTH), calcium and phosphorus levels, and 
eGFR) (data not shown).
DISCUSSION
Pruritus occurred in approximately 20% of children 
with advanced CKD in this study. The proportion 
with pruritus was slightly higher in patients receiving 
dialysis than in those receiving conservative treatment 
(supportive care without dialysis) (23.5% vs. 18.4%). 
However, these results must be regarded with caution, 
due to the low number of analysed children, which is 
a major limitation of this study. Despite this, it is of 
interest that the described prevalence in children is 
close to that found in a cross-sectional representative 
study on chronic itch in haemodialysed patients (1). 
In the current study no itching was found in any child 
in the reference group. Thus, itching in children with 
CKD may be a symptom secondary to systemic di-
sease, e.g. chronic renal failure. Attia et al. (15) made 
different observations, assessing skin lesions in 43 
children treated with haemodialysis. They found pru-
ritus in 18.6% of the children, but this proportion did 
not differ significantly from that of children without 
CKD (18.4% of 38 patients), which, according to the 
authors, indicates that itching in children cannot be 
regarded as a cutaneous manifestation of uraemia (15). 
It should be noted, however, that Attia et al. (15) did 
not specify whether other causes of itching, except for 
kidney disease, were excluded in the children from the 
reference group (e.g. eczema, urticaria, etc.). Another 
study, which included 27 children on peritoneal dia-
lysis, noted pruritus in 22.2% (9), which is comparable 
to our observations of children on dialysis (23.5%). In 
contrast, in a German study of 199 paediatric patients 
on dialysis, pruritus was observed in only 9.1% (16). 
It should be noted that there are few epidemiological 
studies that assess the prevalence of chronic pruritus in 
children and adolescents. In only one cross-sectional 
study, which included 3,775 Norwegian adolescents, it 
was found that pruritus occurred in 8.8% (17), a much 
lower proportion than in the children with CKD.
No research on pruritus in children with CKD who 
do not require dialysis therapy has been published. 
Our findings show that itch occurs even in predialysis 
patients, but in a smaller proportion as compared with 
patients on dialysis. Similar observations apply to 
adults. In patients with lesser degrees of renal damage, 
itching has been reported half as often as in those who 
need dialysis. In the study by Balaskas et al. (18) of 189 
dialysed patients, pruritus occurred in 62% of those on 
peritoneal dialysis and 54% of those on haemodialysis; 
while before dialysis it occurred in only 30% and 28%, 
respectively. In turn, Szepietowski et al.’s study (19) 
Table III. Dry skin and pruritus in children with chronic kidney 
disease (CKD) 
CKD 
without 
pruritus 
n = 57
CKD 
with 
pruritus 
n = 15 p-value
Location of skin dryness, n (%)
  Forearm
  Lower leg
  Abdomen
  Chest
  6 (10.5)
12 (21.1)
  5 (8.8)
  3 (5.3)
5 (33.3)
9 (60.0)
3 (20.0)
2 (13.3)
   0.04
< 0.01
   0.35
   0.28
Skin dryness self-assessment, n (%)
  Absent
  Mild
  Moderate
28 (49.1)
26 (45.6)
  3 (5.3)
5 (33.3)
6 (40.0)
4 (26.7)
  0.04
Duration of skin dryness, years, mean ± SD   7.9 ± 4.8 7.7 ± 5.7    0.63
Skin dryness assessed by dermatologist, mean ± SD
  Forearm
  Lower leg
  Abdomen
  Chest
0.1 ± 0.3
0.2 ± 0.4
0.1 ± 0.3
0.1 ± 0.2
0.5 ± 0.6
0.7 ± 0.6
0.3 ± 0.6
0.1 ± 0.4
< 0.01
< 0.01
   0.06
   0.28
Epidermal hydration (AU), mean ± SD
  Forearm
  Lower leg
  Abdomen
  Chest
29.8 ± 8.6 
25.3 ± 6.8
27.9 ± 9.5
38.1 ± 12.1
28.3 ± 6.5
24.9 ± 7.7 
25.7 ± 6.3
34.2 ± 8.7
   0.59
   0.88
   0.42
   0.36
Transepidermal water loss, g/m2/h, mean ± SD
  Forearm
  Lower leg
  Abdomen
  Chest
8.3 ± 3.9 
8.3 ± 4.6 
9.4 ± 5.9 
8.9 ± 6.0 
  8.5 ± 2.8
10.6 ± 6.8 
  9.6 ± 6.4 
  7.4 ± 2.4 
   0.45
   0.17
   0.97
   0.66
SD: standard deviation; AU: aribtrary units.
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of 130 patients on maintenance haemodialysis reported 
the presence of itching in almost 77%: 40.8% started 
to experience itching after starting haemodialysis, 
whereas in 36.2% pruritus was already present prior to 
haemodialysis. Amatya et al. (20) found an even greater 
disparity in the sensation of itching, depending on the 
stage of CKD; itching occurred in 87% of dialysed pa-
tients, but in only 12% of patients treated conservatively 
without dialysis. 
The higher prevalence of CKD-P in adult patients 
compared with children may be caused by many factors, 
such as comorbidities, initial kidney disease leading to 
renal failure, or simply age. It should also be stressed 
that the sensation of pruritus is subjective. This is parti-
cularly relevant when trials are conducted with children, 
who may have difficulty describing sensations verbally.
What remains debatable is the severity of itching in 
people with CKD. We demonstrated rather low severity 
of pruritus in children with CKD. There was no dif-
ference in the severity of pruritus measured with the 
4-item Itch Questionnaire and VAS scales between the 
groups treated conservatively and those on dialysis. 
It has been suggested that dry skin can cause CKD-P. 
In our study, children with CKD-P assessed their skin 
as drier than did the children without itching. There 
was a significant relationship between the severity 
of dry skin and the occurrence of CKD-P. A number 
of other clinical studies have also found stronger itch 
in areas where dry skin has been diagnosed (17, 18). 
How ever, the relationship between dry skin and pruritus 
is not clear. In objective measurements of the barrier 
function of the skin, such as the assessment of the 
degree of hydration of the skin and TEWL, dryness of 
the skin does not always correlate with pruritus. The 
present study found no correlation between TEWL or 
hydration of the skin and pruritus, analogously to the 
other studies on adults (21–23). In addition, the study 
by Ostlere et al. (21) revealed normal TEWL even in 
patients on haemodialysis.
Dryness of the skin is not the only factor that may 
be associated with CKD-P. Laboratory tests of children 
with CKD show that disorders of calcium phosphate 
metabolism can contribute to the formation of CKD-
P; patients with pruritus have been shown to have a 
significantly higher level of Ca × P than those without 
pruritus. These results are in agreement with the obser-
vations made by Senturk et al. (9) in their research on 
children on peritoneal dialysis. Patients with CKD trea-
ted conservatively without dialysis have less advanced 
stages of CKD (higher GFR), which could explain why 
Ca × P is higher in the dialysis group and that higher 
rates of CKD-P may be only an epiphenomenon. Ho-
wever, pruritus was found in more children with more 
advanced stages of CKD; therefore it is likely that the 
higher prevalence of dry skin in patients with pruritus 
is attributable to more advanced CKD. Furthermore, it 
has been shown that elevated levels of PTH and serum 
phosphorus are important parameters associated with 
pruritus in a given group (4, 21), although such a re-
lationship was not observed in our study. It should be 
noted that many studies showed no effect of disorders 
of calcium phosphate metabolism on the occurrence of 
CKD-P, or that the itching was observed only at very 
high levels of calcium and phosphorus in the blood 
serum. These divergent results indicate the complexity 
of the pathogenesis of CKD-P. It cannot be ruled out 
that the accumulation of uraemic toxins may lead to 
activation of itch receptors in the skin. We found lower 
glomerular filtration rates in patients with pruritus than 
in those without pruritus.
In conclusion, CKD-P occurs not only in adults, but 
also in children with CKD. It is already present in the 
early stages of CKD, and there is a trend towards a 
higher incidence in children undergoing dialysis than 
in those treated conservatively without dialysis. In the 
aetiology of pruritus in children with CKD, dryness 
of the skin, eGFR and imbalance in divalent ions may 
play a role, as demonstrated by a higher incidence of 
dry skin and its higher severity, a higher ratio of Ca × P 
and decreased level of eGFR in children with pruritus 
compared with patients without itch. Further research 
on pruritus in children with CKD is necessary.
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